Quanterix Corporation (QTRX)

Market Cap	498.76M
Revenue (ttm)	109.99M
Net Income (ttm)	-98.15M
Shares Out	37.00M
EPS (ttm)	-1.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	110,686
Open	13.09
Previous Close	13.46
Day's Range	12.67 - 13.39
52-Week Range	6.31 - 44.86
Beta	1.31
Analysts	Sell
Price Target	13.26 (-0.9%)
Earnings Date	Nov 8, 2022

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrume...

• Industry: Life Sciences Tools & Services
• IPO Date: Dec 7, 2017
• Employees: 460
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX

Full Company Profile

Financial Performance

In 2021, Quanterix's revenue was $110.56 million, an increase of 27.99% compared to the previous year's $86.38 million. Losses were -$57.69 million, 83.0% more than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for QTRX stock is "Sell." The 12-month stock price forecast is 13.26, which is a decrease of -0.90% from the latest price.

Price Target

$13.26

(-0.90% downside)

Analyst Consensus: Sell

Stock Forecasts